Digraph

2019-07 FDA approval of imipenem/cilastatin plus relebactam

Parent topics

This topic

Recent activity

You must be signed in to add and move topics and links.

FDA approves new treatment for complicated urinary tract and complicated intra-abdominal infections | FDA
https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-complicated-urinary-tract-and-complicated-intra-abdominal-infections
2019-07 FDA approval of imipenem/cilastatin plus relebactam
Keith Kaye on of Imipenem/Cilastatin + Relebactam | ContagionLive
https://www.contagionlive.com/news/keith-kaye-md-mph-on-the-approval-of-imipenemcilastatin--relebactam
2019-07 FDA approval of imipenem/cilastatin plus relebactam
Keith Kaye, MD, MPH, on the Approval of Imipenem/Cilastatin + Relebactam
https://www.contagionlive.com/publications/contagion/2019/december/keith-kaye-md-mph-on-the-approval-of-imipenemcilastatin--relebactam
2019-07 FDA approval of imipenem/cilastatin plus relebactam AmpC cephalosporinase Extended spectrum beta-lactamases (ESBL)Klebsiella pneumoniae carbapenemase (KPC)